Literature DB >> 9101390

The prediabetic problem: development of non-insulin-dependent diabetes mellitus and related abnormalities.

S M Haffner1.   

Abstract

Non-insulin-dependent diabetes mellitus (NIDDM) is associated with approximately two fold increase in coronary heart disease (CHD) in men and fourfold increase in CHD in women. In most studies, the duration of diabetes and severity of glycemia are only weakly related to CHD in NIDDM, suggesting that the prediabetic period may be important for the increased CHD in NIDDM subjects. Both hyperinsulinemia and/or insulin resistance predict the development of NIDDM. A number of studies have shown that increased cardiovascular risk factors (especially high triglyceride, blood pressure, and small dense low-density lipoprotein (LDL) and low high-density liproprotein (HDL) cholesterol) precede the onset of NIDDM. Recent data from the San Antonio Heart Study suggest that the atherogenic pattern of cardiovascular risk factors is more marked in prediabetic women than in prediabetic men, thus partially explaining the higher risk of CHD in prediabetic women than in prediabetic men. The atherogenic changes in cardiovascular risk factors appear to be mainly due to increased hyperinsulinemia and insulin resistance in nondiabetic subjects. Interventions to reduce cardiovascular disease in NIDDM subjects should emphasize the primary prevention of NIDDM and very aggressive treatment of traditional cardiovascular risk factors in prediabetic subjects. Treatment of hypertension and dyslipidemia in high-risk patients for NIDDM should avoid agents that further worsen insulin resistance (nicotinic acid, beta blockers, and thiazides), as subjects with hypertension and dyslipidemia are already at increased risk of NIDDM.

Entities:  

Mesh:

Year:  1997        PMID: 9101390     DOI: 10.1016/s1056-8727(96)00099-2

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  5 in total

1.  Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease.

Authors:  Orly Vardeny; Hajime Uno; Eugene Braunwald; Jean Lucien Rouleau; Bernard Gersh; Aldo P Maggioni; Michael Domanski; Marc A Pfeffer; Scott D Solomon
Journal:  Am J Cardiol       Date:  2011-04-18       Impact factor: 2.778

2.  Semiquantitative analysis of apolipoprotein A-I modified by advanced glycation end products in diabetes mellitus.

Authors:  Yoshifumi Kurosaki; Tomoaki Tsukushi; Shinichi Munekata; Tohru Akahoshi; Tatsumi Moriya; Zensuke Ogawa
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

3.  Diabetes and urbanization in the Omani population: an analysis of national survey data.

Authors:  Siba Al-Moosa; Sara Allin; Nadia Jemiai; Jawad Al-Lawati; Elias Mossialos
Journal:  Popul Health Metr       Date:  2006-04-24

Review 4.  Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease.

Authors:  Elena Barbu; Mihaela-Roxana Popescu; Andreea-Catarina Popescu; Serban-Mihai Balanescu
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

5.  The diabetes-obesity-hypertension nexus in Qatar: evidence from the World Health Survey.

Authors:  Faleh Mohamed Hussain Ali; Zlatko Nikoloski; Husein Reka; Orsida Gjebrea; Elias Mossialos
Journal:  Popul Health Metr       Date:  2014-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.